Tirzepatide Research Overview
- Popular Name
- Dual GIP And GLP-1 Agonist
- Category
- Weight Loss & Metabolism
- Evidence Tier
- Approved Drug
- Class
- Dual GIP/GLP-1 receptor co-agonist (twincretin); synthetic 39-residue peptide with C18 fatty diacid for albumin binding
- Primary Target
- GIPR (GIP receptor) + GLP-1R (GLP-1 receptor); dual incretin axis activation; pancreatic insulin secretion and hypothalamic appetite suppression
- Half-Life
- ~1 week
- PubMed Citations
- 2,280
- Active Trials
- 174
Mechanism Of Action
It is a dual GIP and GLP-1 receptor agonist. It dramatically slows gastric emptying and sensitizes the body to insulin, resulting in profound appetite suppression and record-breaking weight loss in trials.
Studied For
Type 2 diabetes managementChronic weight management / obesityObstructive sleep apnea in obesity (FDA approved 2024)Non-alcoholic fatty liver disease (NAFLD/MASH)Cardiovascular risk reductionHbA1c loweringBody weight reduction superior to semaglutideInsulin resistance
Sourcing Tirzepatide In The Northeastern Pennsylvania area
Pep Nation Lab supplies research-grade Tirzepatide to verified researchers across Wilkes-Barre, PA, in Luzerne County and the wider Northeastern Pennsylvania area. Every Tirzepatide order ships nationwide with full batch COA documentation, strictly for in vitro laboratory use.
- Service Area
- Wilkes-Barre, PA (Northeastern Pennsylvania)
- County
- Luzerne County, Pennsylvania
- ZIP Codes Served
- 18701
- Shipping
- Nationwide To All 50 States, Including Pennsylvania
- Compound
- Tirzepatide (Dual GIP And GLP-1 Agonist)
- Documentation
- Batch COA Included With Every Order
- Intended Use
- In Vitro Laboratory Research Only
Tirzepatide In Wilkes-Barre - Common Questions
More Research Compounds In Wilkes-Barre
BPC-157 In Wilkes-BarreTB-500 In Wilkes-BarreSemaglutide In Wilkes-BarreRetatrutide In Wilkes-BarreAll Peptides In Wilkes-Barre›
Tirzepatide In Nearby Cities

